Dr. Rebecca Kim is a transplant hepatologist and health services researcher at University of Utah Health. Her research focuses on understanding the impact of social drivers of health (SDoH) on disparities in patients with chronic liver disease (CLD), specifically metabolic dysfunction-associated steatotic liver disease, and how the intervention of modifiable SDoH can improve care for patients with CLD among vulnerable populations. Dr. Kim is a member of University of Utah Health's SDoH Screening Committee and the Health Equity Research Section and Workgroup.

Dr. Daniela Goyes is a Gastroenterology Fellow at Yale University and an incoming Liver Transplant Fellow. Her research and clinical interests center on portal hypertension and autoimmune liver diseases.

Transplant hepatology fellow at the University of Michigan and co-lead of the Liver Fellow Network

Alan L. Hutchison is an MD- and PhD- trained transplant hepatologist-scientist and Clinical Instructor of Medicine at the University of Chicago. He obtained his B.S. in Physics from Yale University, followed by an M.D. and Ph.D. in Computational Biology and Biophysics from the University of Chicago. His PhD thesis focused on developing statistical methods for understanding circadian rhythm data.

Chemical Biology PhD Candidate at the University of Michigan, working under Dr. Jonathan Sexton. Focused on using patient-derived liver organoids to model clinically significant hepatotoxicity.

Dr. Juliane I. Beier is an Assistant Professor at the University of Pittsburgh School of Medicine in the Department of Medicine with a secondary appointment in the Graduate School of Public Health. She is a member of both the Pittsburgh Liver Research Center and the UPMC Hillman Cancer Center.<br>Dr. Beier's research focuses on the interaction between environmental toxicants and metabolic liver diseases.

Dr. Frederick Adams Ekuban is an Assistant Professor of Medicine in the Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition at the University of Louisville School of Medicine. His research program in environmental health and toxicology focuses on elucidating the molecular mechanisms by which environmental pollutants, particularly per- and polyfluoroalkyl substances (PFAS), interact with lifestyle factors to promote liver disease.<br>Dr.

Maria Mironova, MD, MHSc is a research gastroenterology fellow at the University of California, San Diego, specializing in metabolic dysfunction–associated steatotic liver disease. She previously completed a hepatology fellowship at the National Institutes of Health, focusing on non-cirrhotic portal hypertension and omics-based approaches to understanding liver injury in MASLD.

Dr. Bogdanov was born and raised in San Francisco, CA before moving to Los Angeles for his education and training. He obtained his BS in Biochemistry from UCLA, and his MD from the Keck School of Medicine of USC where he remains for his internal medicine residency. Dr. Bogdanov has over twelve years of basic and translational research experience with expertise in tissue injury and regeneration, cellular and molecular signaling, and small molecule drug discovery. Dr. Bogdanov is currently a post-doctoral researcher in the laboratory of Dr.

JORDAN J FELD MD MPH<br>Professor of Medicine, University of Toronto, Ontario, Canada<br>Director of Hepatology, Toronto Centre for Liver Disease, University Health Network<br><br>Dr. Feld trained in GI and Hepatology at the University of Toronto and did post-doctoral training in the Liver Diseases Branch at the National Institutes of Health in laboratory and clinical research in viral hepatitis. After completing a Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health, he returned to Toronto.